Concepedia

C.J. Lansdall

CL

Statistics

Publications

5

Citations

274

H-Index

5

Active since

2014

Affiliations

Roche (Switzerland)(Current)

C.J. Lansdall is an author at Roche (Switzerland) specializing in neurology, neurodegeneration, and dementia.

Publications per year

2014–2024

5

Publications

5

Establishing Clinically Meaningful Change on Outcome Assessments Frequently Used in Trials of Mild Cognitive Impairment Due to Alzheimer's Disease

C.J. Lansdall, Fiona McDougall, Lesley M. Butler et al. · The Journal of Prevention of Alzheimer s Disease · 2022 · 87 citations · Full text

, , +12

The neuroanatomical and neurochemical basis of apathy and impulsivity in frontotemporal lobar degeneration

Luca Passamonti, C.J. Lansdall · Current Opinion in Behavioral Sciences · 2018 · 74 citations · Full text

, , +17

Psychometric Properties of the Clinical Dementia Rating — Sum of Boxes and other Cognitive and Functional Outcomes in a Prodromal Alzheimer's Disease Population

Fiona McDougall, Chris J. Edgar, Michaela Mertes et al. · The Journal of Prevention of Alzheimer s Disease · 2021 · 52 citations · Full text

, , +17

An effective treatment for Alzheimer's disease must consider both amyloid and tau

C.J. Lansdall · Bioscience Horizons The International Journal of Student Research · 2014 · 44 citations · Full text

, , +17

Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force

Davide Angioni, J Cummings, C.J. Lansdall et al. · The Journal of Prevention of Alzheimer s Disease · 2024 · 17 citations · Full text

, , +12

1–5 of 5